Today, NIDA issued a Request for Information (RFI) from the research community and any other interested parties regarding the establishment of a standard unit dose of THC in order to facilitate research on cannabis.
Ample evidence shows methadone and buprenorphine reduce overdose deaths, prevent the spread of diseases like HIV, and enable people to take back their lives, but there are restrictions on who can prescribe these medications.
Provides parents with research-based skills to help keep their children drug-free.
A plain language summary of the behavioral therapies, medications, and devices that can be used to treat substance use disorders.
Describes principles important to consider when developing drug abuse prevention programs and discusses issues relevant for family, school, and community settings.
Over the past few years, NIDA’s Office of Translational Initiatives and Program Innovations (OTIPI) has used these and other funding mechanisms to help biotech startups develop incredibly innovative technologies that translate addiction science into healthcare and consumer products.
Common sense and a growing body of research suggest that patients with opioid use disorder (OUD) who receive acute care in an emergency department will be at reduced risk for later overdose if they are initiated on medications to treat their OUD.
The National Institutes of Health will award 12 grants to form the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder (OUD) in criminal justice settings nationwide.
One of the major challenges in health science today is that not enough patients participate in clinical trials and other studies. Without volunteers willing and able to participate in studies testing new treatments or therapeutic approaches for cancer or Alzheimer’s, for example, researchers cannot test their effectiveness.
Subscribe to Evidence-Based Practices
Reducing healthcare’s reliance on potentially addictive opioid pain relievers has been one of the pillars of federal efforts to reverse the opioid crisis.